{
    "nctId": "NCT03402529",
    "briefTitle": "Added Value of Contrast Enhanced Spectral Mammography, CESM. A Pilot Study.",
    "officialTitle": "Added Value of Contrast Enhanced Spectral Mammography, CESM in Diagnostics and Size Estimation of Malignant Lesions in Breast. A Pilot Study.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 47,
    "primaryOutcomeMeasure": "Number of participants with change of treatment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients diagnosed with breast cancer and whom are planned for primary surgery\n* Signed informed consent\n\nExclusion Criteria:\n\n* Ongoing pregnancy\n* Ongoing lactation\n* Allergy against iodine contrast\n* Treatment with metformin (against diabetes)\n* Renal failure\n* Hyperthyroidism\n* Severe heart condition\n* Myasthenia gravis\n* Implants\n* Inability to understand study information",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}